Vann

What Vann does

Vann is a UK-based digital health platform operating as Vann Limited (incorporated in the United Kingdom), founded in 2020 by Ani Haykuni, a two-time cancer survivor who began cancer treatment in 2015 and established the Ani Haykuni Cancer Treatment Support Foundation in 2016. The company's stated objective is to improve cancer care globally and contribute to cancer research. Operations are based in Oxford, United Kingdom, with the platform distributed globally through Apple's iOS App Store and Google Play Store as a self-serve mobile application available for free download. Headcount per firmographics is 1-10 employees, and the company has been recognised with the CEO of the Year Award 2023 (Innovation / R&D category) and named an Innovator of the Year finalist.

The core product is the Vann mobile application, which combines community engagement with structured research functionality. Key product features include in-app research studies focused on the impact of cancer and treatments on quality of life, Real World Evidence (RWE) collection, educational content on topics such as radiology and breast surgery, a "Sea of Tranquillity" feature presenting calming imagery, and a "Make a Smile" tool allowing users to dedicate activities (e.g., a run) to others in the community. The technology is described as a mobile application with built-in online studies and surveys; no AI/ML components, public APIs, SDKs, MCP servers, or third-party integrations are disclosed in the available sources. The platform was reportedly tested onsite at hospitals, day treatment units, and ambulance vehicles during cancer treatments.

Vann's go-to-market combines product-led distribution (free app-store download) with a community-led approach leveraging patient networks and the founder's prior charitable work. The company identifies two customer segments: cancer patients and survivors (primary end users seeking community and support) and cancer researchers and pharmaceutical companies (organisations seeking patient-reported outcomes and Real World Evidence). Pricing tiers, paid plans, and a formal revenue model are not publicly disclosed; no enterprise contracts, paying research customers, or licensing arrangements are disclosed. Capital sources to date are non-dilutive grants from Innovate UK and OxLEP Business (with the European Regional Development Fund), alongside backing by Oxford University Innovation, the University of Oxford's technology transfer company. The platform launched in October 2022, and a portion of profits is reportedly directed to the founder's separate charitable foundation.

Name

Vann

Legal name

Vann Limited

Website

https://thevann.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Vann is a UK-based mobile platform serving cancer patients and survivors with community support and in-app research studies, while collecting Real World Evidence for cancer researchers and pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Digital Health / Oncology Patient Support Platform

NAICS

Social Assistance (624), Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

akta.pro secondary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

Keywords

• Cancer patient support
• Real-world evidence
• Mobile health platform
• Patient community app
• Cancer research platform

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Digital Platform Services: Platform providing community, support, research studies, and real-world evidence collection for cancer patients. Revenue model not explicitly disclosed in sources.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels11 records

Core offering

Vann operates a mobile application platform for people affected by cancer that delivers community support, educational content, in-app research studies on treatment quality of life, and Real World Evidence collection. The app is distributed through iOS App Store and Google Play Store, offering features such as activity dedication ("Make a Smile"), a calming image gallery ("Sea of Tranquillity"), surveys, and dashboards for tracking community engagement. The platform also bridges patients with cancer researchers and pharmaceutical companies by aggregating patient-reported outcomes and RWE data.

Product overview

Vann is a unified digital platform designed for people affected by cancer. The core offering consists of the Vann mobile app (available on iOS and Android) which combines community support, cancer research studies, Real World Evidence collection, and a 'make a smile' motivation feature. The platform also includes educational content covering topics such as radiology, breast surgery, and cancer care. Vann serves as a bridge between cancer patients and researchers/pharmaceutical companies, enabling patient voices to contribute to cancer research and drug development. The platform is not modular; it is a single integrated product with multiple features including research studies, community forums, educational content, and a motivation tool where users can dedicate activities to others.

Differentiator

Problem solved

Functional benefit

Products and services

• Vann App A mobile application for iOS and Android that provides community support, motivation, information, and research participation tools to people affected by cancer (patients and those in remission). The app includes in-app research studies, surveys, Real World Evidence collection, a "Make a Smile" activity dedication feature, a "Sea of Tranquillity" calming image gallery, educational blog content, and dashboards tracking community engagement and survey data.

Quantifiable outcome

• Working with hundreds of cancer patients since 2016 through the Ani Haykuni Cancer Treatment Support Foundation

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/vann.cancer
• LinkedInlinkedin.com/company/vann
• Instagraminstagram.com/vann.positive

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vann